Cargando…
Atorvastatin Attenuates Programmed Death Ligand-1 (PD-L1) Induction in Human Hepatocellular Carcinoma Cells
Liver cancer is the sixth most common cancer worldwide with high morbidity and mortality. Programmed death ligand 1 (PD-L1) is a major ligand of programmed death 1 receptor (PD1), and PD1/PD-L1 checkpoint acts as a negative regulator of the immune system. Cancers evade the host’s immune defense via...
Autores principales: | Shwe, Thuzar Hla, Pothacharoen, Peraphan, Phitak, Thanyaluck, Wudtiwai, Benjawan, Kongtawelert, Prachya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395726/ https://www.ncbi.nlm.nih.gov/pubmed/34445462 http://dx.doi.org/10.3390/ijms22168755 |
Ejemplares similares
-
Inhibitory Effect of Hesperidin on the Expression of Programmed Death Ligand (PD-L1) in Breast Cancer
por: Kongtawelert, Prachya, et al.
Publicado: (2020) -
Sesamin protects against neurotoxicity via inhibition of microglial activation under high glucose circumstances through modulating p38 and JNK signaling pathways
por: Kongtawelert, Prachya, et al.
Publicado: (2022) -
Sesamin Attenuates VEGFA-Induced Angiogenesis via Inhibition of Src and FAK Signaling in Chick Chorioallantoic Membrane Model and Human Endothelial EA.hy926 Cells
por: Keratibumrungpong, Tanyaporn, et al.
Publicado: (2023) -
Comparison of glucose derivatives effects on cartilage degradation
por: Phitak, Thanyaluck, et al.
Publicado: (2010) -
Anticancer Activities of Hesperidin via Suppression of Up-Regulated Programmed Death-Ligand 1 Expression in Oral Cancer Cells
por: Wudtiwai, Benjawan, et al.
Publicado: (2021)